BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11779840)

  • 1. Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density.
    Galm O; Rountree MR; Bachman KE; Jair KW; Baylin SB; Herman JG
    Genome Res; 2002 Jan; 12(1):153-7. PubMed ID: 11779840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development.
    Sakashita K; Koike K; Kinoshita T; Shiohara M; Kamijo T; Taniguchi S; Kubota T
    J Clin Invest; 2001 Oct; 108(8):1195-204. PubMed ID: 11602627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes.
    Aoki E; Ohashi H; Uchida T; Murate T; Saito H; Kinoshita T
    Leukemia; 2003 Sep; 17(9):1903-4. PubMed ID: 12970793
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of aberrant methylation of the p15INK4B gene promoter.
    Uchida T
    Methods Mol Med; 2002; 68():239-49. PubMed ID: 11901506
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
    Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased DNA methylation in the HoxA5 promoter region correlates with decreased expression of the gene during tumor promotion.
    Watson RE; Curtin GM; Hellmann GM; Doolittle DJ; Goodman JI
    Mol Carcinog; 2004 Sep; 41(1):54-66. PubMed ID: 15352125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel method to quantify local CpG methylation density by regional methylation elongation assay on microarray.
    Zhang D; Wang Y; Bai Y; Ge Q; Qiao Y; Luo J; Jia C; Lu Z
    BMC Genomics; 2008 Jan; 9():59. PubMed ID: 18237388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
    Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis.
    Teofili L; Martini M; Luongo M; Diverio D; Capelli G; Breccia M; Lo Coco F; Leone G; Larocca LM
    Leukemia; 2003 May; 17(5):919-24. PubMed ID: 12750706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic regional methylation assay for determination of CpG methylation density.
    Zhang Z; Chen CQ; Manev H
    Anal Chem; 2004 Nov; 76(22):6829-32. PubMed ID: 15538812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormal methylation of several tumor suppressor genes in sporadic breast cancer].
    Zemliakova VV; Zhevlova AI; Strel'nikov VV; Liubchenko LN; Vishnevskaia IaV; Tret'iakova VA; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2003; 37(4):696-703. PubMed ID: 12942643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
    Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
    Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
    Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
    Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection method for methylation density on microarray using methyl-CpG-binding domain protein.
    Luo J; Zheng W; Wang Y; Wu Z; Bai Y; Lu Z
    Anal Biochem; 2009 Apr; 387(2):143-9. PubMed ID: 19084498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
    Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K
    Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
    Herman JG; Graff JR; Myöhänen S; Nelkin BD; Baylin SB
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9821-6. PubMed ID: 8790415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.